AstraZeneca
AZN
#44
Rank
$213.04 B
Marketcap
$68.73
Share price
1.21%
Change (1 day)
5.12%
Change (1 year)

P/E ratio for AstraZeneca (AZN)

P/E ratio as of March 2023 (TTM): 64.8

According to AstraZeneca's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 64.8396. At the end of 2021 the company had a P/E ratio of 402.

P/E ratio history for AstraZeneca from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
2021402880.4%
202041.0-57.68%
201996.8116.68%
201844.752.59%
201729.348.32%
201619.7-35.16%
201530.4-57.6%
201471.8146.77%
201329.1207.22%
20129.47

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
22.4-65.38%๐Ÿ‡บ๐Ÿ‡ธ USA
28.3-56.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
7.18-88.92%๐Ÿ‡บ๐Ÿ‡ธ USA
22.9-64.64%๐Ÿ‡บ๐Ÿ‡ธ USA
49.9-23.11%๐Ÿ‡บ๐Ÿ‡ธ USA
18.7-71.15%๐Ÿ‡ซ๐Ÿ‡ท France
12.9-80.16%๐Ÿ‡บ๐Ÿ‡ธ USA
18.7-71.22%๐Ÿ‡บ๐Ÿ‡ธ USA
25.0-61.40%๐Ÿ‡บ๐Ÿ‡ธ USA
4.43-93.17%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.